Norwegian scabies in a patient treated with Tripterygium glycoside for rheumatoid arthritis
AUTOR(ES)
Bu, Xiaolin, Fan, Juan, Hu, Xiaoli, Bi, Xinling, Peng, Bin, Zhang, Denghai
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2017-08
RESUMO
Abstract: We report an 80-year-old male patient with severe rheumatoid arthritis who was treated with tripterygium glycoside, an immunosuppressive agent made from the extract of a Chinese medicinal herb called Tripterygium wilfordii Hook F. The patient had no apparent skin lesions before the treatment, but he developed aggressive hyperkeratotic lesions with rapid progression after using tripterygium glycoside. He was repeatedly diagnosed with eczema, but treatment failed to achieve efficacy. Interestingly, a microscopic examination of the lesions revealed numerous scabies mites and eggs. Thus, we confirmed the diagnosis of Norwegian scabies infection. Treated with crotamiton 10% cream and 10% sulfur ointment for one month, the patient's clinical symptoms disappeared.
Documentos Relacionados
- Asthma in an AIDS patient with Norwegian scabies induced by bathing.
- Kaposi's sarcoma in a patient with rheumatoid arthritis and polymyositis treated with corticosteroids.
- Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine.
- Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone.
- Severe, disseminated, life threatening herpes zoster infection in a patient with rheumatoid arthritis treated with methotrexate.
